*EMBARGOED All research presented at the 2023 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 22, 2023, at 3:00 pm PT.
Oral 31 – Increased Risk of Respiratory Syncytial Virus Among Patients With Inflammatory Bowel Disease
Tuesday, October 24, 2023 | 9:00 AM – 9:10 AM PT | Location: Ballroom B
Author Insight from Freddy Caldera, DO, MS, University of Wisconsin School of Medicine and Public Health, Madison, WI
What’s new here and important for clinicians?
This research demonstrates that patients with IBD are at increased risk for developing an infection or severe infections related to RSV. Risk for infection and hospitalization was present amongst all age groups >18 years of age. Medical comorbidities such as diabetes, chronic liver disease, chronic kidney disease and cardiovascular disease portended an increased risk for infection. Patients on immunomodulators and anti-tumor necrosis factor therapy were at greater risk of infection. Gastroenterology providers should educate their patients regarding the potential risks of RSV infection. Two novel inactivated, non-live RSV vaccines have been approved in the United States for individuals aged 60 years and older. Providers should recommend immunization to limit potential consequences of infection, especially for their patients on immunosuppressive therapies or with multiple comorbidities.
What do patients need to know?
Patients with inflammatory bowel disease should be educated on their increased risk for infections related to RSV, as well as their increased risk for hospitalization related to RSV infections. For those who are aged 60 years and older, they should consider discussing with their health care provider about getting vaccinated with an RSV vaccine.
Read the Abstract
Freddy Caldera, DO, MS, University of Wisconsin School of Medicine and Public Health, Madison, WI
fcaldera [at] medicine.wisc.edu
Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.